AGP Executive Report
Last update: 11 hours agoCE Mark & Women’s Health Diagnostics: Italy’s Mestrualia won CE approval for its Sobek non-invasive blood-and-saliva test, aiming to move earlier chronic-disease assessment and women’s prevention into clinical pilots. Oncology Manufacturing: Fujifilm and Taiho partnered to optimize next-generation ADC manufacturing using AraLinQ, targeting more reliable, scalable production of cancer therapies. Precision Radiation Therapy: Samsung Medical Device unit signed an LOI with Accuray to explore imaging-guided, motion-managed radiosurgery combining BodyTom CT imaging with CyberKnife. Hospital Lab Expansion: CareWell Health in East Orange opened a new automated medical laboratory plus a molecular diagnostics unit for faster testing across GI, women’s health, TB, hepatitis, STIs, MRSA and more. Digital Diagnostics Workflow: Sunway Medical Centre Velocity became the first in Southeast Asia to launch NORAV’s NORAV Clinical Management System to centralize ECG and related cardiac testing into one connected platform. Alzheimer’s Pipeline Milestone: Actinogen Medical is nearing topline results for its XanaMIA Phase 2b/3 oral cortisol-targeting therapy, positioning it as simpler than infusion-based anti-amyloid options. Health Tech + Care Delivery: Thesis Care and Cottage Health announced an AI care-team partnership to support patient engagement and close care gaps. Public Health & Safety: Karnataka’s pharma gas leak in Yadgir killed three workers and injured two, while Odisha signed 10 MoUs to strengthen trauma care, medical education and health infrastructure. Fraud & Access: Two people posing as KATH staff were convicted and fined for forging IDs and practicing medicine without registration. Business Watch: Manipal Health’s IPO debuted with a sharp jump, valuing the hospital chain around $9B, as investors weigh growth against premium valuation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.